{"id":"https://openalex.org/W2553801733","doi":"https://doi.org/10.1182/blood.v122.21.1588.1588","title":"Integrated Genetic Profiling Of JAK2 Wildtype Chronic-Phase Myeloproliferative Neoplasms","display_name":"Integrated Genetic Profiling Of JAK2 Wildtype Chronic-Phase Myeloproliferative Neoplasms","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W2553801733","doi":"https://doi.org/10.1182/blood.v122.21.1588.1588","mag":"2553801733"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.1588.1588","doi":"https://doi.org/10.1182/blood.v122.21.1588.1588","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1588.1588","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077063317","display_name":"Raajit K. Rampal","orcid":"https://orcid.org/0000-0002-0355-6368","observed_orcids":["https://orcid.org/0000-0002-0355-6368"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raajit K. Rampal","raw_affiliation_strings":["Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044552886","display_name":"Sean M. Devlin","orcid":"https://orcid.org/0000-0002-6801-720X","observed_orcids":["https://orcid.org/0000-0002-6801-720X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sean M. Devlin","raw_affiliation_strings":["Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103416354","display_name":"Jay P. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jay P. Patel","raw_affiliation_strings":["Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019408533","display_name":"Kristina Marie Knapp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristina M. Knapp","raw_affiliation_strings":["Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106726030","display_name":"Minal A. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Minal Patel","raw_affiliation_strings":["Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000119117","display_name":"Joel R. Greenbowe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel R Greenbowe","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lauren E Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lauren E Young","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103325426","display_name":"Jie He","orcid":"https://orcid.org/0000-0002-1326-4166","observed_orcids":["https://orcid.org/0000-0002-1326-4166"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jie He","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kai Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kai Wang","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056410481","display_name":"Michelle K. Nahas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michelle K. Nahas","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079433880","display_name":"Roman Yelensky","orcid":"https://orcid.org/0000-0002-5356-0111","observed_orcids":["https://orcid.org/0000-0002-5356-0111"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Roman Yelensky","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066068230","display_name":"Geoff A. Otto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Geoff A. Otto","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029183165","display_name":"Doron Lipson","orcid":"https://orcid.org/0009-0004-2738-5702","observed_orcids":["https://orcid.org/0009-0004-2738-5702"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Doron Lipson","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113642947","display_name":"Philip J. Stephens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Philip J. Stephens","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111578811","display_name":"Vincent A. Miller","orcid":"https://orcid.org/0000-0003-1667-3771","observed_orcids":["https://orcid.org/0000-0003-1667-3771"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vincent A. Miller","raw_affiliation_strings":["Foundation Medicine, Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025660159","display_name":"Ross L. Levine","orcid":"https://orcid.org/0000-0002-7884-1905","observed_orcids":["https://orcid.org/0000-0002-7884-1905"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross L. Levine","raw_affiliation_strings":["Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5029183165","https://openalex.org/A5044552886","https://openalex.org/A5056410481","https://openalex.org/A5066068230","https://openalex.org/A5079433880","https://openalex.org/A5103325426","https://openalex.org/A5103416354","https://openalex.org/A5106726030","https://openalex.org/A5111578811","https://openalex.org/A5113642947"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4392738181"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.27127492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"122","issue":"21","first_page":"1588","last_page":"1588"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9739999771118164},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.8669999837875366},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/asxl1-mutation","display_name":"ASXL1 mutation","score":0.8560000061988831},{"id":"https://openalex.org/keywords/tet2-mutation","display_name":"TET2 mutation","score":0.996999979019165},{"id":"https://openalex.org/keywords/dnmt3a-mutation","display_name":"DNMT3A mutation","score":0.7820000052452087},{"id":"https://openalex.org/keywords/epigenetic-modifiers","display_name":"epigenetic regulators","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.7899755239486694},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.61678546667099},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5875047445297241},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.5656532645225525},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.4850265383720398},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.42747724056243896},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.4250788986682892},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.41298624873161316},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4103129506111145},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3975414037704468},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3900296986103058},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.31845390796661377},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.30988574028015137},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17393705248832703}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.1588.1588","doi":"https://doi.org/10.1182/blood.v122.21.1588.1588","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1588.1588","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6800000071525574}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2150058579","https://openalex.org/W2611711560","https://openalex.org/W91111500","https://openalex.org/W2762863431","https://openalex.org/W4283271588","https://openalex.org/W2761199703","https://openalex.org/W2098715171","https://openalex.org/W1523078789","https://openalex.org/W2152553331","https://openalex.org/W2361488268"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2,276,461],"Myeloproliferative":[3],"Neoplasms":[4],"(MPNs),":[5],"including":[6,148,312,436],"Polycythemia":[7],"Vera":[8],"(PV),":[9],"Essential":[10],"Thrombocythemia":[11],"(ET),":[12],"and":[13,36,43,57,111,151,171,184,205,212,233,243,290,338,358,392,409,443,449,502,504,542,570,598,606],"Primary":[14],"Myelofibrosis":[15],"(PMF)":[16],"are":[17,23,46,79,374,490,571,602],"clonal":[18],"hematopoietic":[19],"disorders.":[20],"JAK2V617F":[21,157,257],"mutations":[22,45,258,279,296,323,342,351,425,437,450,467,476,508,537,561,585,594],"observed":[24,47,280,307],"in":[25,48,68,91,126,259,281,285,291,297,308,316,324,329,339,343,352,365,381,389,398,401,413,426,438,445,451,457,498,516,533,558,564,586,589,595,599,604],"approximately":[26],"90-95%":[27],"of":[28,34,51,71,86,99,105,114,123,141,246,270,272,288,310,332,367,396,416,447,459,464,527,552,583,611],"PV":[29,53,150],"cases,":[30],"but":[31],"only":[32],"40-50%":[33],"ET":[35],"PMF":[37],"cases.":[38,460],"Although":[39],"JAK2":[40,88,127,166,565],"exon":[41],"12":[42],"LNK":[44],"the":[49,69,83,97,102,112,121,165,241,268,273,353,359,452,524,581,608],"majority":[50,70],"JAK2V617F-negative":[52,72,282,382,419,517,528,590,612],"patients,":[54,333],"candidate":[55],"gene":[56,540],"exome":[58],"sequencing":[59,190,252],"studies":[60],"to":[61,81,93,224,239,255,434,469,479],"date":[62],"have":[63,430],"not":[64,431,555],"identified":[65,134,322,350,385,394,423],"activating":[66],"oncogenes":[67],"ET/PMF":[73],"patients.":[74],"Thus,":[75],"further":[76],"genetic":[77,106,124,609],"investigations":[78],"needed":[80],"define":[82],"mutational":[84,525],"architecture":[85],"these":[87,100,404,465,578],"wildtype":[89,128,566],"MPNs":[90],"order":[92],"gain":[94],"insight":[95],"into":[96],"biology":[98],"diseases,":[101],"clinical":[103],"implications":[104,463],"events":[107],"that":[108,265,372,378,506,523,593],"do":[109],"occur,":[110],"elucidation":[113],"potential":[115],"therapeutic":[116],"targets.":[117],"Aims":[118],"To":[119],"characterize":[120],"spectrum":[122],"alterations":[125,546],"chronic-phase":[129],"myeloproliferative":[130],"neoplasms.":[131],"Methods":[132],"We":[133,321,349,421],"32":[135],"patients":[136,261,417,428,499],"with":[137,319,335,418,481,492,500,573],"a":[138,159,313,330,386,414,549],"confirmed":[139],"diagnosis":[140],"an":[142,495,510],"MPN":[143,283,427,529],"(per":[144],"2008":[145],"WHO":[146],"criteria),":[147],"MF,":[149],"ET,":[152],"who":[153],"were":[154,192,222,266,284,306,346,477],"negative":[155,568],"for":[156,164,210,217,231,237,513],"using":[158,197],"CLIA-certified":[160],"allele":[161],"specific":[162,244],"assay":[163],"disease":[167,376],"allele.":[168],"Genomic":[169],"DNA":[170,232,439],"total":[172,235],"RNA":[173],"was":[174],"isolated":[175],"from":[176],"formalin":[177],"fixed":[178],"paraffin":[179],"embedded":[180],"(FFPE)":[181],"tissue,":[182],"blood":[183],"bone":[185],"marrow":[186],"aspirates.":[187],"Adaptor":[188],"ligated":[189],"libraries":[191,221],"captured":[193,220],"by":[194],"solution":[195],"hybridization":[196],"two":[198,260],"custom":[199],"baitsets":[200],"targeting":[201],"374":[202],"cancer-related":[203],"genes":[204,207,214,408,441,531],"24":[206],"frequently":[208,215,563],"rearranged":[209,216],"DNA-seq,":[211],"258":[213],"RNA-seq.":[218],"All":[219],"sequenced":[223],"high":[225],"depth":[226],"(Illumina":[227],"HiSeq),":[228],"averaging":[229],">590X":[230],">20,000,000":[234],"pairs":[236],"RNA,":[238],"enable":[240],"sensitive":[242],"detection":[245,271],"genomic":[247],"alterations.":[248],"Results":[249],"High":[250],"coverage":[251],"allowed":[253],"us":[254],"identify":[256],"(allele":[262],"burden":[263],"3-5%)":[264],"below":[267],"limit":[269],"CLIA":[274],"assay.":[275],"most":[277],"common":[278,603],"ASXL1":[286,475,507,560,584],"(22%":[287],"patients)":[289],"TET2":[292],"(9%).":[293],"Taken":[294],"together,":[295],"known":[298],"epigenetic":[299,534,600],"modifiers":[300],"(ASXL1,":[301],"TET2,":[302],"DNMT3A,":[303],"EZH2,":[304],"MLL)":[305],"43%":[309],"samples,":[311],"MLL-PTD":[314],"mutation":[315],"one":[317,390,399],"patient":[318,369,400],"PMF.":[320],"spliceosome":[325,344],"components":[326,345,362],"(SRSF2,":[327],"U2AF1),":[328],"subset":[331,415],"consistent":[334,491],"previous":[336],"reports,":[337],"each":[340],"case":[341],"mutually":[347],"exclusive.":[348],"JAK-STAT":[354],"pathway":[355,361,455],"(MPL,":[356],"TYK2)":[357],"RAS":[360],"(KRAS,":[363],"NF1)":[364],"9%":[366],"this":[368],"cohort,":[370],"suggesting":[371],"there":[373],"alternate":[375],"alleles":[377],"activate":[379,411,539],"signaling":[380,412,454,596],"MPN.":[383,420,518,559,613],"RNA-sequencing":[384],"ETV6-ABL1":[387],"fusion":[388,407,543],"patient,":[391],"we":[393],"amplification":[395],"PIK3CA":[397],"our":[402],"cohort;":[403],"data":[405,493,521],"suggest":[406,505],"amplifications":[410],"also":[422],"novel":[424,466,536,550],"which":[429,538,547],"been":[432],"reported":[433,557],"date,":[435],"repair":[440],"(ATM":[442],"BRCA)":[444],"25%":[446],"cases":[448],"Notch":[453],"(NOTCH1-4)":[456],"31%":[458],"functional":[462],"remain":[468],"be":[470],"elucidated.":[471],"In":[472],"univariate":[473],"analysis,":[474],"found":[478],"associate":[480],"impaired":[482,496,574],"overall":[483,575],"survival":[484,497],"(Figure":[485],"1,":[486],"p=0.049).":[487],"These":[488,520],"findings":[489,579],"demonstrating":[494],"MDS":[501],"PMF,":[503],"represent":[509],"important":[511],"biomarker":[512],"adverse":[514],"outcome":[515,588],"Conclusions":[519],"demonstrate":[522,592],"spectra":[526],"includes":[530],"implicated":[532],"regulation,":[535],"signaling,":[541],"genes/copy":[544],"number":[545],"provide":[548],"mechanism":[551],"oncogenic":[553],"activation":[554],"previously":[556],"occur":[562],"Philadelphia-Chromosome":[567],"MPNs,":[569],"associated":[572],"survival.":[576],"Collectively,":[577],"support":[580],"importance":[582],"predicting":[587],"MPN,":[591,605],"effectors":[597],"regulators":[601],"illustrate":[607],"heterogeneity":[610],"Disclosures:":[614],"Rampal:":[615],"Foundation":[616],"Medicine:":[617],"Consultancy.":[618,622],"Levine:Foundation":[619],"Medicine,":[620],"Inc:":[621]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}